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ABSTRACT Primary psychiatric disorders where skin changes ap-
pear most frequently include: delusions of parasitosis, body dys-
morphic disorder, neurotic excoriations, dermatitis artefacta, and 
trichotillomania. In all these diseases the primary pathologic con-
dition is of psychiatric nature, and the skin changes are secondary 
and self-induced. In this review we wanted to present the epidemi-
ology, clinical pictures, and treatment options for these disorders. 
These patients are more frequently seen in dermatology clinics, as 
they may be unwilling to acknowledge a psychiatric basis for their 
psychical symptoms. If we want the treatment to be effective and 
timely, it is important for the dermatologist to understand the un-
derlying psychopathology of these conditions. Treatment should 
be gradual. An initially supportive, nonconfrontational, empathic 
approach to the patient is indicated. Immediate confrontation re-
garding the suspicion that the patient’s lesions are self-induced 
can be counterproductive in that the patient will often refuse 
treatment. Frequent visits and symptomatic topical treatments 
are useful in the beginning. The goal is to establish a trusting and 
supportive enough relationship with the patient so that he or she 
will accept a psychiatric referral to explore the complex personality 
and behavioral issues that often underlie these conditions.
KEY WORDS: delusions of parasitosis; body dysmorphic disorder; 
neurotic excoriations; dermatitis artefacta; trichotillomania
INTRODUCTION
Psychocutaneous diseases were classified by Ko-
blenzer in 1987 as primary dermatologic disorders 
and primary psychiatric disorders (1). The first group 
includes severe dermatoses due to their impact on 
the patient’s physical appearance and well-being. 
Long-lasting and extensive skin diseases such as pso-
riasis, atopic dermatitis, pemphigus, or epidermolysis 
may lead to demoralization, anxiety, and depression. 
Similar feelings can be caused by cosmetically un-
acceptable dermatoses such as acne conglobata or 
alopecia. These feelings affect approximately 30% of 
dermatologic patients. The quality of life in such pa-
tients is diminished because of the tremendous im-
pact on their private life, interfering with outdoor ac-
tivities, acceptance by others, and relationships with 
other people.
In the second group of primary psychiatric disor-
ders, patients have intact skin at first, but something 
starts to appear on the body because of psychiatric 
conditions. This group includes: delusions of parasit-
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osis, body dysmorphic disorder, and self-inflicted der-
matoses (factitious disorders) – neurotic excoriations, 
dermatitis artefacta and trichotillomania (1).
DESLUSIONS OF PARASITOSIS
Delusions of parasitosis (DP) is a monosymptom-
atic hypochondrial psychosis where patients manifest 
the circumscribed false belief of being infested with 
parasites. Frequently, it is the only manifestation of 
the patient’s psychosis, so these patients most often 
present to dermatologists and entomologists rather 
than to psychiatrists.
The disease has been known for several hundred 
years ago under different names. Browne in 1690 de-
scribed this condition as “Morgellons disease” (2), and 
Thibierge in 1984 as acarophobia (3). Savely et al. in 
2006 recommend the term Morgellon disease to de-
scribe a condition characterized by fibers attached to 
the skin (4). The entity appears to be little more than 
a designation for delusional parasitosis. Some other 
authors have discussed the utility of the term, find-
ing it useful for building a therapeutic alliance with 
patients with delusions of parasitosis (5,6).
DP occurs primarily in middle-aged or older wom-
en, although the condition has been reported in all 
age groups and in men. Patients come to the clinician 
in an anxious and excited state, with a history of visits 
to multiple physicians without satisfaction. They pres-
ent a detailed history that includes visual and tactile 
hallucinations, often bringing with them „proof“ of 
parasitic infection contained in matchboxes, beakers, 
plastic wrap, jars, or clothing lint (Figure 1).
Patients present with varying degrees of excoria-
tions, ulcers, and scars, as they attempt to remove or 
destroy the imagined parasites with knives, needles, 
tweezers, or nails (Figure 2). The usual sites are those 
that are easily accessible (7). 
Actual infestation must always be ruled out. Mi-
croscopic examinations of the material brought by 
patient reveals the content to be skin bits, hair, scales, 
lint, and dirt with no parasites, but there is little use 
trying to convince the patient of this fact (8).
DP can be associated with schizophrenia, obses-
sive-compulsive disorder, bipolar disorder, depres-
sion, and anxiety disorders. 
The only method to treat the situation that under-
lies delusions of parasitosis is the administration of 
psychotropic medications. Pimozide has been used 
the longest, but lately risperidone, olanzapine, sero-
tonergic antidepressants, and aripiprazole are given 
more frequently (9-12). Besides pimozide, haloperi-
dol is one of the psychopharmacological options in 
the treatment of these patients (13). There has been 
an increase in combined psychiatric and dermatolog-
ic collaboration to treat DP using a multidisciplinary 
approach with dermatologists working with psychia-
trists (14). When treating DP it is important that the 
physician establishes a therapeutic alliance with the 
patients. Without this alliance it is difficult to con-
vince patients to take the necessary medications (15). 
Empathetic listening, expressing concern about how 
the problem is affecting the patient’s life, and exam-
ining the material that the patient brings in helps to 
establish a trustful relationship (1).
Figure 1. Delusions of parasitosis. Plastic jar with skin 
particles. No parasites were found.
Figure 2. Delusions of parasitosis. Multiple excoria-
tions in female patient. She brought the jar shown in 
Figure 1.
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BODY DYSMORPHIC DISORDER
Body dysmorphic disorder (BDD) represents an 
excessive concern with a presumed defect in physical 
appearance despite normal or only minimal objective 
anomalous findings on the skin. 
The disorder, also known as dysmorphophobia, 
was first documented in 1886 by Morselli. The disease 
was recognized by the American Psychiatric Associa-
tion as a body dysmorphic disorder, as the original 
term implies a phobia of people, not a reluctance to 
interact socially because of poor body image (16). 
BDD is marked by a preoccupation with an imagined 
or trivial defect in appearance, but a preoccupation 
causing clinically significant distress or impairment in 
social, occupational, or other functioning. Untreated, 
it tends to be chronic and is a potentially debilitating 
psychiatric illness which may lead to social withdraw-
al and professional failure, as well as depression and 
suicide in severe cases (17).
The prevalence of BDD is estimated to be from 
1% in the general population to 12% in dermatology 
clinic patients, equally prevalent in women and men. 
It can be associated with major depressive disorder, 
phobia, and the spectrum of obsessive-compulsive 
disorders (1). BDD can occur in adults or in children, 
usually beginning during adolescence when a large 
amount of change is happening to the body. 
Patients present with intensely articulated dis-
tress about various body parts. They have worrisome 
thoughts, consuming hours of each day, including 
repeated examination in mirrors, concealing the “de-
fect” and asking others for reassurance. They spend 
many hours a day attempting to conceal or correct 
perceived flaws that are often not real. If the per-
ceived flaw has any foundation in reality, it is typi-
cally minor but severely exaggerated by the patient, 
such as minimally expressed acne comedonica with 
only 2-3 papules (18). Patients often wish to change 
or improve aspects of their physical appearance that 
they find troublesome and seek dermatological treat-
ment, cosmetic surgery, or other cosmetic modifica-
tion for their concealment, although the outcome 
usually does not resolve the symptoms of BDD itself 
(19). Skin picking sometimes manifests as a symptom 
of the disease and can both create a larger imperfec-
tion as well as harm the individual (20).
BDD is under-diagnosed, although it has been re-
ported for more than one hundred years all over the 
world (21). The inconsistency in prevalence is indica-
tive of the importance of education on what BDD is 
and how it can be diagnosed. It is crucial  for physi-
cians to identify its symptoms and help patients un-
derstand the need for psychiatric help. Selective sero-
tonin reuptake inhibitors (SSRIs) with individual and 
group cognitive behavioral therapy (CBT) have been 
shown to be most effective and should be used as a 
first line of therapy (22,23). SSRIs, clomipramine, flux-
etine, fluvoxamine, sertraline, and paroxetine have 
been found to be effective in both delusional and 
non-delusional cases (24-26).
NEUROTIC EXCORIATIONS
Neurotic excoriations (NE) are conditions in which 
patients induce skin lesions through repetitive, com-
pulsive excoriations of their skin. Unlike patients with 
dermatitis artefacta, these patients admit their role in 
the production of the lesions.
Skin lesions are caused by picking, rubbing, and 
scratching because patients have poor impulse con-
trol and cannot suppress the desire to inflict injury on 
themselves. 
The condition seems to be associated with under-
lying obsessive-compulsive disorder, depressive dis-
orders, and anxiety disorders. However, the behavior 
has also been associated with social stressors, includ-
ing unemployment, financial loss, and marital hard-
ships (27).
It is estimated that 2% of dermatologic clinic pa-
tients have the diagnosis of NE with the predomi-
nance among middle-aged females (28). Patients 
with NE often describe significant itch leading to 
persistent scratching, which is frequently antedated 
by considerable psychological stressors. They scratch 
themselves mostly with their nails but sometimes 
also with “helping devices” (Figure 3).
Patients present with multiple excoriations in vari-
ous stages of evolution and healing, with post-inflam-
matory hyperpigmentation and scaring. The distribu-
tion of the lesions reflects their self-inflicted nature 
with most being on the extensor surfaces of the ex-
tremities, upper back, and face, sparing unreachable 
Figure 3. Neurotic excoriations. Home-made “help-
ing device” for scratching found with male patient.
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areas (Figure 4). The bilateral upper lateral back area 
is usually spared. The “butterfly sign” is a characteris-
tic feature, as the areas of where the patient cannot 
reach bear a resemblance to the shape of butterfly 
wings (29).
The clinician must evaluate the patient for causes 
of pruritus and rule out possible internal diseases, 
uremia, liver diseases, and neoplasms, in particular 
lymphomas.
The treatment depends on the precise nature of 
the underlying psychiatric diagnosis involved. The 
first-line treatment for NE may be SSRIs as they can 
reduce depressive and compulsive symptoms (30,31). 
Anxiolytics can be used for short-term treatment 
when an acute social stressor or comorbid anxiety 
is involved. Non-pharmacologic treatment includes 
cognitive therapy, behavior modification, an eclectic 
approach, and psychodynamic psychotherapy (32). 
Dermatological management includes oral antihis-
taminines, topical antipruritics, cool compresses, and 
phototherapy (27).
DERMATITIS ARTEFACTA
Dermatitis artefacta (DA), also known as factitial 
dermatitis is a disorder of self-injurious behavior. In 
DA cases patients intentionally feign symptoms and 
produce signs of a disease in an attempt to assume 
the role of a patient. A patient with this condition pro-
duces cutaneous lesions in order to fulfill an uncon-
scious psychological need (33). Unlike malingering 
patients who engage in similar behavior for external 
or “secondary” gain (such as monetary reward or re-
lief from occupational or other social responsibilities), 
the factitious patient seek the “primary gain” of the 
emotional and psychological benefits accrued by 
those who are ill (1).
Dermatitis artefacta is frequently seen in individu-
als who are immature personalities when facing a 
stressful life situation. The visible skin lesions can be 
interpreted as an attempt of non-verbal communica-
tion, a silent appeal for help. Dermatitis artefacta is 
predominant in women; the age of onset varies sig-
nificantly from adolescence through the seventh and 
eight decade of life. The patient population is also as-
sociated with working in or having family members 
in health-related careers. This may be related to the 
hypochondriacal tendencies of the patient, or to the 
fact that the patient is inclined to learn to falsify ail-
ments through contact with those with actual dis-
ease (34).
Figure 4. Neurotic excoriations. Typical excoriations 
made by “helping device” shown in Figure 3.
Figure 5. Dermatitis artefacta. Typical artefacts on 
the face of a school girl.
Figure 6. Dermatitis artefacta. Linear artefacts on the 
upper parts of the back that are accesible to the pa-
tient.
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Many of these patients display a rather neurotic 
emotional disorder and not psychosis. The majority 
of patients with this condition have borderline per-
sonality disorder (35). Some of these patients have 
suffered from an emotional deficit early in life, or have 
a history of sexual or physical abuse and are therefore 
unable to develop a stable body image. They may 
suffer from profound psychological distress, depres-
sion, and poor impulse control. The act and sensation 
of self-induced pain and physical lesions may relieve 
their inner sense of isolation and distress (33).
Morphology of DA is often bizarre and does not 
conform to typical presentations of known dermato-
ses. Patients are often unable to provide a clear his-
tory of the initial appearance or evolution of the pro-
cess and typically deny their role in the production of 
the lesions (1). Often, the patient appears unmoved 
by the unsightly and bizarre lesions, but their family 
members are upset and suspicious of how the lesions 
evolved (36).
Although it has long been known that patients 
with dermatitis artefacta may present with lesions in 
virtually all areas of the body that can mimic many 
dermatoses, some common elements may hint at this 
diagnosis. Lesions are often in areas readily accessible 
to the patient and may have geometric patterns or 
angulated borders surrounded by completely healthy 
skin. A wide range of histologic findings are found, 
but the histopathology is unrevealing (37). Character-
istically, skin changes heal rapidly under the occlusive 
dressing.
DA presents in a great variety of clinical forms de-
pending on the patient’s creativity and the method 
used to produce the lesions. The most common pre-
sentations are: excoriations, ulcers, blisters, pannicu-
litis, crusting, eczematous lesions, edemas, purpuras, 
and bruises (38). Skin lesion are produced by scratch-
ing, burns or cauterization, application of different 
chemical or plants, and sometimes by self-injections 
of different products such as milk (39), or urine (38).
Following patients with DA for many years, we no-
ticed lesions in different configurations, in usual and 
unusual shapes, single or multiple, mostly confined 
to areas accessible to the patient’s hands. Skin chang-
es were mostly located on the face, chest, and limbs, 
but sometimes all over the body. There was strenu-
ous denial by around 50% of patients that they took 
part in provoking the lesions, while in others it was 
discovered that they produced the skin lesions by 
scratching, abrasions, cutting with knives and razor 
blades, burning with cigarettes and irons, applying 
chemicals such as washing powders and strong sani-
tary cleaners, irritant plants, and even injecting some 
ingredients under the skin (such as saw-dust). All this 
provoked heavy irritant dermatitis with erythema, 
erosions, and sometimes ulcerations (Figure 5, 6, 7, 8, 
9, 10, 11). Lesions healed rapidly under the occlusive 
dressing. In many of them different scars were visible 
as well (40).
As in all cases of factitious diseases, the clinician 
must rule out possible disease entities that are con-
Figure 7. Dermatitis artefacta. Abrasions on the glu-
teal region in a female patient. For many years she 
produced lesions only on her face.
Figure 8. Dermatitis artefacta. Arteficial eczematous 
lesions on the abdominal region and both legs ori-
gianted by pouring chemical on the skin.
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sistent with the history and clinical findings. Unusual 
presentations of common illnesses and rare condi-
tions must be considered. However, exhaustive search 
for primary skin pathology without supporting clini-
cal evidence may compound the problem and actu-
ally perpetuate the patient’s factitious behavior.
Treatment must be delicate. An initially support-
ive, non-confrontational, empathic approach to the 
patient is indicated (36). Immediate confrontation 
regarding the suspicion that the patient’s lesions are 
self-induced can be counterproductive in that the pa-
tient will often refuse treatment. Frequent visits and 
symptomatic topical treatments are useful in the be-
ginning. The clinician must be careful not to collude 
in the patient’s abnormal behavior and, ultimately, 
the recognition of the patient’s role in the production 
of the lesions must be broached. The goal is to estab-
lish a trusting and supportive enough relationship 
with the patient that he or she will accept a psychi-
atric referral to explore the complex personality and 
behavioral issues that often underlie this condition.
Psychiatric treatment includes a combination of 
pharmacological and behavioral therapy. A dialecti-
cal behavioral therapy involving a structural behav-
ioral therapeutic program is recommended for bor-
derline personality disorder (28). Psychotropic medi-
cations can be used to treat depression and anxiety. 
SSRIs such as fluoxetine, sertraline, paroxetine, and 
fluvoxamine are typically treatment for compulsive, 
self-injurious behavior. Anxiolytics such as buspirome 
and benzodiazepines can be prescribed if anxiety is a 
dominant feature (36). 
Dermatological treatment includes wounds de-
bridement, topical antibiotics, and epitelization assis-
tance measures. Occlusive dressing or other means 
of preventing manipulation by the patient avert fur-
ther cutaneous damage and lead to healing of the 
lesions.
TRICHOTILLOMANIA
Trichotillomania (TTM) is an impulse control disor-
der characterized by repetitive hair pulling, resulting 
in self-induced hair loss. According to psychiatric cri-
teria, the patient should also experience tension prior 
to hair pulling or when resisting such behavior and 
experience relief after the behavior is complete. In 
addition, the patient must demonstrate impairment 
in functioning or significant distress (27). Comorbid 
Figure 9. Dermatitis artefacta. Erosions and scars on 
shoulder. Patient denied that she took any part in 
provoking the lesions.
Figure 10. Dermatitis artefacta. Skin changes on 
both arms provoked by multiple cigarette burns.
Figure 11. Dermatitis artefacta. Older and recent 
scars remaining after razor blade cuts.
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psychiatric disorders are depression, anxiety, and ob-
sessive-compulsive disorder (OCD) (1).
Some studies on college students have found the 
prevalence of TTM to range from 1.0% to 13.3% (41). 
In TTM, despite normal hair density, patients pres-
ent with different hair lengths, including tapered 
ends demonstrating new growth and blunt ends 
representing broken hairs. Hairs may be broken mid-
shaft or appear as small black dots or stubbles at the 
scalp surface. Excoriations may be found as well. The 
affected region typically has an unusual shape (Fig-
ure 12, 13). The pull test is also negative, i.e. the hair 
does not pull out of the scalp effortlessly. The scalp 
feels rough where the hair was pulled out (42). TTM 
is often misdiagnosed as alopecia areata. In alope-
cia areata, the bare regions of the scalp are smooth, 
peach-colored, and the hair-pull test is positive (42). 
Body areas involved typically include the scalp, eye-
lashes, eyebrows, and pubic hair, with the majority of 
patients pulling hair from more than one site. Rarely, 
this is followed by the ingestion of the hair, leading to 
trichobezoar (43). 
Diagnosis of TTM is supported by findings of tri-
chomalacia, characterized by melanin pigment casts, 
increased density of catagen phase hairs, and trau-
matized hair bulbs without perifollicuar inflamma-
tion (44).
Trichotillomania in young children generally has a 
benign course. It may be accompanied by other evi-
dence of stress, such as regressive behavior, bed wet-
ting, or nightmares. A gentle exploration by the phy-
sician of changes at home which might be the source 
of that stress, may aid the parents in supporting their 
child through the difficult period. In the treatment of 
patients in this age group, it can be helpful to offer 
the child a wooly toy to pluck. Trichotillomania in an 
older child or adolescent may prove more persistent, 
may involve the eyebrows and eyelashes as well as 
the hair of the scalp, and may carry the same uncon-
scious implications of punishment or autoeroticism. 
It is necessary to be frank with the parents about the 
nature of the problem, and to stop them from seeking 
the more “acceptable” and less threatening explana-
tions for alopecia, such as endocrinopathy or dietary 
deficiency, through a multitude of unnecessary and 
expensive tests. In children, pulling of hair frequently 
becomes the focus of a power struggle between the 
parent and the child. It is of great importance that 
the parents understand and see that. By insisting that 
the habit be stopped, they are pressuring an already 
stressed child, and perhaps, paradoxically, ensuring 
that the habit will persist (45).
Treatment of TTM includes pharmacological and 
non-pharmacological therapies. Recommended ther-
apy is administration of SSRIs, specifically escitalopha-
rm, sertraline, fluoxetine, citalopram, and paroxetine, 
which can be used as monotherapy. Clomipramine, a 
tricyclic antidepressant, may also be used (46). Atypi-
cal antipsychotics including risperidone and aripipra-
zole at low doses have appeared to be beneficial in 
combination with SSRIs or as monotherapy (44).
Non-pharmacological therapies include behav-
ior modification through habit reversal therapy. It 
involves self-monitoring of behaviors, coping strate-
gies, relation therapy, social support, and competing 
responses, such as sitting on the hands or clenching 
the fists until the tension resolves (42). Cognitive be-
havior therapy, hypnotherapy, and insight-oriented 
psychotherapy have been effective, especially in the 
pediatric population (47).
Figure 12. Trichotillomania. Figure 13. Trichotillomania.
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In dermatological treatment, topical steroids can 
improve secondary inflammation, and topical min-
oxidil may increase the rate of hair regrowth (27).
DISCUSSION
For all primary psychiatric disorders where the 
skin lesions appear secondary, the most effective un-
derlying strategy is to first establish a strong thera-
peutic rapport with the patient. Various pharmaco-
logical and non-pharmacological therapies can then 
be attempted to successfully manage these patients. 
Although the underlying cause of skin changes in 
primary psychiatric disorders is of a psychiatric na-
ture, patients with these disorders frequently seek 
help from dermatologists as they may be unable to 
acknowledge or are not fully aware that they are in-
ducing the physical lesions on themselves. Therefore, 
it is important to understand that these disorders can 
be more effectively managed if the dermatologist is 
able to familiarize themselves with the epidemiology, 
clinical presentation, differential diagnosis, and treat-
ment of these conditions (27).
Diagnostic clues are found in the nature and the 
evolution of the lesions as well as in the ambivalent 
combination of dependency on doctors and hostility 
toward them revealed in the patient’s medical histo-
ry. Management of these skin lesions means dealing 
with the complex emotional issue of a basic antago-
nism in the dermatologist-patient relationship. Both 
the dermatologist and the dermatologic nursing staff 
should show an understanding and nonaggressive 
attitude (48).
For a better prognosis and successful treatment, 
early diagnosis of these skin changes is crucial along 
with supportive consultations with dermatologists, 
psychiatrists, and general practitioners. Course and 
prognosis are fundamentally determined by the un-
derlying psychopathology. In patients with severely 
manifested psychiatric disorders the recurrent self-
defeating and destructive behaviors are likely to con-
tinue. Thus, in such patients the recurrencies are fre-
quent, and long-term and intense psychiatric therapy 
is recommended.
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